ScinoPharm, a leading global supplier of active pharmaceutical ingredients (APIs), today announced the appointment of Nana Hsieh Hung as Vice President of Administration. She will report directly to Dr. Jo Shen, President and CEO of ScinoPharm.

ScinoPharm Taiwan, Ltd. (TWSE1789) a leading global supplier of active pharmaceutical ingredients (APIs), announced unaudited revenues totaling NT$3.948 billion for 2011, and before-tax net profits of NT$1.124 billion, for an EPS of $1.82.

ScinoPharm Taiwan, Ltd. (TWSE1789) a leading global supplier of active pharmaceutical ingredients (APIs), announced that it will begin trading its shares today on the Taiwan Stock Exchange Board.

ScinoPharm, a leading global supplier of active pharmaceutical ingredients (APIs), today announced the appointment of Patricia Chou as Chief Financial Officer and Vice President of Corporate Development.

ScinoPharm, an active pharmaceutical ingredient (API) specialist, today announced the company has been certified as an Authorized Economic Operator (AEO) by the Taiwanese Customs office.